Monitor integration of Calabrian and margin progression; raised guidance suggests management confidence but the GAAP EPS miss and leverage increase (2.0x from 1.2x) warrant caution. Next quarter will test whether organic volume growth and expansion from the acquisition translate into cash flow. With no share buyback in Q2, capital allocation focus is on debt reduction.
Price Chart
Executive Summary
Ecovyst reported Q2 2026 sales of $250.0M, beating consensus of $236.9M (+5.5%), and raised full-year 2026 Adjusted EBITDA guidance to $195-$207M from $180-$195M. However, GAAP diluted EPS of $0.10 missed the $0.19 consensus by 47% due to acquisition-related costs and higher depreciation. The Calabrian SO2 acquisition closed June 30, contributing to a net debt leverage ratio increase to 2.0x from 1.2x.
Key Financial Metrics
Key Facts
- Q2 2026 sales $250.0M (+42% YoY vs $176.1M), consensus $236.9M
- GAAP diluted EPS $0.10 vs consensus $0.19 (-47% miss); adjusted diluted EPS $0.21 (+10.5% beat)
- Adjusted EBITDA $53.1M (+27% YoY), within guidance range
- Full-year 2026 guidance raised: Adj. EBITDA $195-$207M (from $180-$195M), sales $1,020-$1,060M (from $890-$970M)
- Completed acquisition of Calabrian SO2 business for $178.5M on June 30, 2026
- Net debt leverage ratio increased to 2.0x from 1.2x due to acquisition financing
- No share repurchases in Q2; $146.5M remaining under $450M buyback authorization
- Operating cash flow from continuing ops $55.2M YTD vs $25.3M prior year
Financial Impact
Sales beat by $13.1M (+5.5%); GAAP EPS miss by $0.09 (-47%); guidance raise implies ~$20M incremental Adjusted EBITDA at midpoint
Risk Factors
- Acquisition integration risk for Calabrian business
- Higher leverage (net debt to EBITDA 2.0x) constrains financial flexibility
- Sulfur cost pass-through dependency could compress margins if sulfur prices decline
- Potential for softer industrial demand for virgin sulfuric acid in H2 2026
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302843536 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 6w ago | Insider Buy | $10.54 $10.88 | ▲ +3.23% | ▲ +3.67% | $9.97 (−5.41%) |
Aug 5, 2026 11w ago | Press Release | $11.45 $11.00 | ▼ −3.93% | ▼ −3.77% | $9.97 (−12.93%) |
Jun 30, 2026 17w ago | 8-K | $12.00 $11.83 | ▼ −1.42% | ▼ −1.29% | $9.97 (−16.92%) |
Jun 11, 2026 19w ago | Institutional Cluster | $12.94 $13.09 | ▲ +1.16% | ▲ +0.62% | $9.97 (−22.95%) |
May 5, 2026 25w ago | 8-K | $14.73 $14.68 | ▼ −0.34% | ▼ −1.72% | $9.97 (−32.32%) |
May 4, 2026 25w ago | 8-K | $14.12 $14.73 | ▲ +4.32% | ▲ +3.52% | $9.97 (−29.39%) |
Feb 26, 2026 34w ago | 8-K | $11.45 $11.27 | ▼ −1.57% | ▼ −1.12% | $9.97 (−12.93%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers